The European Council of Minister last week said it is ready to begin negotiations with the European Parliament, having agreed ...

Knight will have the exclusive rights to distribute, promote, market and sell the products in Canada, and said it will begin ...

US biotech Regeneron Pharmaceuticals (Nasdaq: REGN) and French pharma major Sanofi (Euronext: SAN) on Saturday presented ...

Sanofi announced it is punting more than $9 billion to acquire Blueprint Medicines and its Ayvakit, BLU-808 and immunology ...